scout
|Articles|October 25, 2013

Special Reports

  • Genitourinary Cancers
  • Volume 1
  • Issue 1

Immune Response in Patients with RCC

Jeffrey A. Sosman, MD, professor of medicine, director, Melanoma and Tumor Immunotherapy Program, Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, discusses immune response in renal cell carcinoma.

Jeffrey A. Sosman, MD, professor of medicine, director, Melanoma and Tumor Immunotherapy Program, Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, discusses immune response in renal cell carcinoma.

The treatment of advanced renal cell carcinoma (RCC) remains a major challenge for clinicians.Read more > >

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME